192
R. Samudrala et al. / Bioorg. Med. Chem. 15 (2007) 186–193
to give 2.01 g of an oil (81%), Rf (72:18:10 CH2Cl2/
NH2OH(aq)/MeOH) 0.51. H NMR (CDCl3) d 2.05 (s,
2HTR: 50-AATCCGTCGAGCAGAGTTAGGGTTA
GGGTTAG-30
1
2H), 3.18 (m, 1H), 3.35 (m, 8H), 3.50 (m, 6H), 3.61
(m, 12H). 13C NMR (CDCl3) d 59.1, 70.48, 70.51,
70.56, 70.62, 71.9, 72.0. IR (thin film) 3522, 3364,
3290, 2891 cmꢁ1. Anal. Calcd for C13H29NO6: C,
52.86; H, 9.90; N, 4.74. Found: C, 52.73; H, 9.93; N,
4.51.
NHE-27: 50-TGGGGAGGGTGGGGAGGGTGGGG
AAGG-30
Fluorescence quenching (Fig. 2) was used to construct
the titration curves shown in Figure 3. Analogs were
mixed with DNA for 2 min at 25 ꢁC and fluorescence
spectra were recorded. For PIPER, 3 mL of buffer con-
taining 100 mM KCl, 1 mM EDTA, and 33.8 nM PIP-
ER were titrated with G-rich ssDNA 2HTR (2.04 lM
strands), the complementary C-rich ssDNA (2.04 lM
strands), or duplex from mixing of the two strands
(2.65 lM duplex). A similar experiment used NHE-27
(3.36 lM strands), its C-rich complementary strand
(2.7 lM strands), or duplex (1.42 lM duplex). Because
of potential protonation effects with PIPER, the buffer
solutions were either 10 mM Tris–HCl (pH 8.0) or
200 mM MES (pH 6.5). No difference was observed
between either pH.
4.4. N,N0-Di-[10-(2,5,8,12,15,18-hexaoxanonadecyl)]per-
ylene-3,4,9,10-bis(dicarboximide) (5)
2,5,8,12,15,18-Hexaoxa-l0-nonadecanamine (9, 200 mg,
0.68 mmol), 3,4,9,10-perylenetetracarboxylic dianhy-
dride (7, 133 mg, 0.34 mmol), imidazole (2.56 g), and
Zn(OAc)2 (0.03 g , 0.15 mmol) were heated at 165 ꢁC
overnight. The reaction mixture solidified upon cooling
and was dissolved in MeOH. A few drops of acetic acid
were added and the mixture was stirred for 15 min and
then eluted through an Amberlite IR-120 (+) ion ex-
change column (pre-washed with water, then 2 N HCl)
to remove imidazole. Lastly, imidazole-free material
was obtained by column chromatography on basic alu-
mina (0.4–0.8% MeOH in EtOAc) to give 0.09 g (28%)
of deep-red solid, mp 143–144 ꢁC, Rf (2:1 MeOH/
EtOAc) 0.70. Further elution gave 0.07 g (22%) of less
For compound 5, a 2.2 mL solution of 168 nM 5 in
Tris–HCl buffer (10 mM) containing 100 mM KCl
and 1 mM EDTA was titrated with G-rich ssDNA
2HTR (496 lM strands), the complementary C-rich
ssDNA (530 lM strands), or duplex from mixing of
the two strands (496 lM duplex). A similar experi-
ment used NHE-27 (437 lM strands), its C-rich
complementary strand (580 lM strands), or duplex
(218 lM duplex).
1
pure material. H NMR (CDCl3) d 3.28 (s, 12H), 3.42
(m, 8H), 3.56 (m, 8H), 3.61 (m, 12H), 3.72 (m, 4H),
3.99 (m, 4H), 4.19 (m, 4H), 5.72 (m, 2H), 8.58 (m,
4H), 8.63 (m, 4H). 13C NMR (CDCl3) d 52.2, 59.1,
69.4, 70.5, 70.62, 70.63, 72.0, 123.2, 123.6 (b), 126.4,
129.7, 131.7 (b), 134.6, 164.0. IR (KBr) 1700,
1654 cmꢁ1. Anal. Calcd for C50H62N2O16 1/2H2O: C,
62.82; H, 6.64; N, 2.93. Found: C, 62.91; H, 6.46; N,
2.93.
Data for both compounds were recorded as ꢁDF/Fo,
where ꢁDF is the difference in fluorescence at each
DNA concentration from Fo, the initial fluorescence of
the drug. Fluorescence changes were fitted to the simple
non-interacting site model of mass action. This model
assumes a ligand (L) binds to a DNA site (D) according
to:
4.5. N,N0-Di-[10-(3,6,9-trioxadecyl)]perylene-3,4,9,10-
bis(dicarboximide) (6)
3,6,9-Trioxadecylamine (90 mg, 0.55 mmol), 7 (120 mg,
0.31 mmol), imidazole (1 g), and Zn(OAc)2 (catalytic
amount) were combined in a reaction flask and heated
to 160 ꢁC for 18 h. The reaction mixture was then cooled
to rt, stirred for 10 min with 50 mL of water, and
extracted with CHCl3 (3· 50 mL). The combined ex-
tracts were washed with 5% HCl (aq) to remove residual
imidazole, dried over MgSO4, and concentrated by rota-
ry evaporation to give 200 mg of crude product. This
was recrystallized from hexane/CHCl3 to give 145 mg
L þ D ꢀ LD
ð1Þ
with a dissociation constant Kd = ([L][D])/[LD]. The val-
ues [L], [D], and [LD] are molar concentrations of the
free ligand, free DNA sites, and ligand-bound DNA
sites, respectively. The number of sites per DNA strand
is given by:
½Dꢃ ¼ n½Dꢃ ;
ð2Þ
o
where [D]o is the concentration of DNA in strands or
duplex and n is the number of sites per DNA. Fitting
of data to the above model was done using the non-lin-
ear least squares function of Kaleidagraph (Synergy
Software, Reading, PA) with Kd and ꢁDFmax/Fo as
adjustable parameters. Titrations were performed in
triplicate (all data are indicated in Fig. 3), and the
computed values of the parameters are reported in Ta-
ble 2 for mean standard deviations of these triplicate
determinations. For compound 5, the number of sites
per strand was fitted with n = 1. For PIPER, multiple
binding sites were evident (n ꢄ 1), and n was fixed at
32 and 27 for double strand 2HTR and NHE-27,
respectively.
1
(77%) of 6, Rf (9:1 CHCl3/MeOH) 0.58; H NMR in
agreement with the literature.17 13C NMR (CDCl3) d
39.5, 59.2, 68.0, 70.3, 70.7, 70.8, 72.0, 123.2, 123.3,
126.4, 129.4, 131.5, 134.6, 163.5. IR (KBr) 1691,
1654 cmꢁ1
.
4.6. Titration curves
The DNAs used were synthesized by solid phase meth-
ods and obtained from Midland Certified Reagent Com-
pany (Midland, TX). The sequences, previously shown
to be converted to quadruplex structures by small
molecules,12,33 were: